Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Vertex Pharma sees positive results in Phase 2 trials of new non-opioid pain killer
04:15pm, Monday, 04'th Apr 2022
Reshma Kewalramani, Vertex Pharmaceuticals CEO, joins 'Power Lunch' to discuss the data behind a pain relieving medicine that's different from opioids, what the Phase 3 trials will look like and more.
A Recession Could Be Coming: 3 Stocks to Buy to Be Prepared
05:56am, Sunday, 03'rd Apr 2022
One potential early warning sign of a recession is already flashing.
Worried About Rising Interest Rates? These 2 Growth Stocks Could Help
10:45am, Friday, 01'st Apr 2022
Rate hikes shouldn't rattle these stocks as their businesses carry relatively modest debt.
Why April Has the Bulls Beaming
04:33pm, Thursday, 31'st Mar 2022
April is the best month for the Dow since 1950 - averaging about a 2% gain.
Vertex Pharmaceuticals reports positive data on non-opioid pain medicine
10:52am, Thursday, 31'st Mar 2022
CNBC's Meg Tirrell joins 'Squawk Box' to report the details from a mid-stage study conducted by Vertex Pharmaceuticals over its non-opioid pain medicine.
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
11:31pm, Tuesday, 29'th Mar 2022
Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Biotech is ‘oversold': top stocks to capitalize on the pullback
08:40pm, Monday, 28'th Mar 2022
The SPDR S&P Biotech ETF is down close to 25% year-to-date but Michael Yee sees several names in this space that look promising at current valuations. Why did XBI recover in recent weeks?
3 No-Brainer Stocks to Buy if the U.S. Dips Into a Recession
05:51am, Sunday, 27'th Mar 2022
This stock trio can help patient investors thrive if an economic contraction becomes a reality.
ORIC Stock Plunges on Discontinuation of Oncology Candidate
12:47pm, Wednesday, 23'rd Mar 2022
ORIC declines on discontinuation of pipeline candidate ORIC-101 following planned interim analyses of two phase Ib studies.
Vertex (VRTX) to Begin Pivotal Study on Kidney Candidate
09:47am, Wednesday, 23'rd Mar 2022
Vertex's (VRTX) pivotal phase III study on VX-147 targeting a broad patient population with proteinuric kidney disease mediated by two mutations in the APOL1 gene (AMKD) is expected to begin later thi
Missed Out on Moderna? My Best Biotech Stock to Buy and Hold
06:30am, Wednesday, 23'rd Mar 2022
This company is working with Moderna on an exciting program.
Vertex: More Opportunities Ahead
08:05am, Tuesday, 22'nd Mar 2022
The core cystic fibrosis business has an opportunity to grow further.
Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know
07:33pm, Wednesday, 16'th Mar 2022
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $248.52, moving +0.62% from the previous trading session.
Is Vertex Pharmaceuticals Stock Bound for a Pop?
02:14pm, Monday, 14'th Mar 2022
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is up 1.6% at $240.25 at last check.
Nervous About Stagflation? Buy These 2 Growth Stocks
10:53am, Saturday, 12'th Mar 2022
It's harder for stagflation to hurt a company's bottom line when costs don't change much.
